ÂÜÀòÂÒÂ×

John L. Seamans is a seasoned professional with extensive experience in the biomedical field, currently serving as Manager at the Michigan Biomedical Venture Fund since November 2021, where responsibilities include managing investments and strategic support for early-stage biomedical startups affiliated with the University of Michigan. Seamans holds multiple board observer roles with various organizations, including Arborsense, Inc., Invenio Imaging, Courage Therapeutics, and Mountain Pass Solutions. Prior roles encompass Director of Clinical Engineering and Principal Engineer at Delphinus Medical Technologies, focusing on the development of innovative imaging systems for breast cancer detection, along with significant contributions at GE Healthcare as Cardiovascular Applications Design Architect and Senior Systems Engineer. Educationally, Seamans is pursuing an MBA at the University of Michigan's Ross School of Business while holding degrees in Biomedical Engineering and Electrical Engineering from the same institution.